Article
Uptake of publicly-funded reproductive genetic carrier screening in Australia
2026-03-27
Abstract excerpt
<title>Abstract</title> <p>Reproductive genetic carrier screening (RGCS) for cystic fibrosis, spinal muscular atrophy and fragile X syndrome was added to Australia’s Medicare Benefits Scheme in November 2023. We analysed national uptake of publicly funded RGCS and compared testing volumes with birth numbers from November 2023 to August 2025. During this period, 206,321 patient tests and 7,554 partner tests were p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 037e640f-0678-54c6-8e08-be6ef28bbac3
- DOI
- 10.21203/rs.3.rs-8537045/v1
